COVID-19: China Healthcare Implications for Private Equity Investors Presentations July 14, 2020 Helen Chen Justin Wang Stephen Sunderland
Life Sciences & Pharma Executive Insights How Value-Based Contracts Bring Value to Biopharma July 23, 2020 Biopharmaceutical executives have engaged in extensive debates about the need for and effectiveness of value-based contracts (VBCs) ever since the…
Organization & Performance Published Articles How Not If: Remote Working and the ‘Next Normal’ May 18, 2020 In this article we review a range of potential remote working operating models and summarise our analytical framework for quantifying and assessing how…
Life Sciences & Pharma Published Articles How to Approach an Increasingly Challenging and Subjective Japanese Pricing Environment October 8, 2020 Japan remains on balance an attractive pharmaceutical market, with favorable volume dynamics, generally attractive pricing and broad and unfettered market…
Strategy Presentations Global Situation Report Insights: Edition 2 June 9, 2020 The L.E.K. Global Situation Report is a uniquely rich, current, and customisable collection of indicators that provide a powerful recovery planning aide.
Organization & Performance Published Articles Working From Home after COVID-19: businesses need to allow flexibility, or they will lose… May 4, 2020 As businesses consider the likely shape of recovery from lockdown, we have researched the impact of the current enforced experience of working from home…
Life Sciences & Pharma Presentations European Disease Progression Monitor: Edition 8 June 17, 2020 In light of new data surrounding the impact of COVID-19 on the population, health services, pharmaceutical industry and wider economy, L.E.K.’s Healthcare…
